Palatal WoundNCT07089433
Palatal Shield Technique for Graft Donor Site Healing
A study testing Palatal stent as wound dressing and Conventional suturing in people with Palatal Wound, run by University of Cagliari at 1 site in Italy.
Trial summary
This randomized clinical trial aims to compare two techniques for managing the palatal donor site following gingival graft harvesting: a palatal stent made of flowable composite resin versus conventional suturing. Read more about this study
- Who is it for?
- Any ageHealthy volunteers can take part
- Conditions the study is for
- Palatal Wound
- What is being tested?
- Palatal stent as wound dressing and Conventional suturing
- Type of treatment
- Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 20 participants
- Where
- 1 siteItaly
- Study dates
- 1 Jul 2023to 15 Jul 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- Healthy volunteers accepted
- Child, Adult, Older adult
Who may be able to join
- Adult patients (≥18 years old) requiring periodontal or peri-implant mucogingival surgery involving palatal graft harvesting.
- Systemically healthy patients without medical conditions affecting wound healing.
- Patients free of active periodontal disease at the time of surgery.
- Patients able and willing to comply with postoperative instructions, complete questionnaires, and attend follow-up appointments.
- Patients providing informed written consent to participate in the study.
Who cannot join
- Patients with systemic diseases that could influence wound healing (e.g., diabetes, autoimmune disorders).
- Patients with active periodontal disease.
- Patients taking medications known to affect bleeding or healing (e.g., anticoagulants, immunosuppressants, steroids).
- Patients who are pregnant or breastfeeding.
- Patients who have undergone previous surgical interventions in the palatal donor area.
- Patients with allergies or hypersensitivity to composite resin materials or collagen-based products.
- Patients unable or unwilling to comply with postoperative instructions or follow-up visits.
- Patients with poor oral hygiene or uncontrolled plaque accumulation.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Morbidity Following Free Gingival Graft Harvesting With or Without the Use of the Palatal Shield Technique as a Wound Dressing: A Randomized Trial
This randomized clinical trial aims to compare two techniques for managing the palatal donor site following gingival graft harvesting: a palatal stent made of flowable composite resin versus conventional suturing. The primary goal is to identify which method provides superior patient-reported outcomes (PROMs), thus optimizing postoperative comfort and overall patient well-being.
Systemically healthy patients, free of active periodontitis, requiring a palatal graft as part of periodontal or peri-implant mucogingival surgeries will be recruited and randomized into two groups. The experimental group will receive a palatal shield made of flowable composite resin adhesively secured to adjacent teeth, whereas the control group will undergo conventional suturing. In both groups, a collagen hemostatic sponge will be placed to aid hemostasis.
Read more
Primary endpoints include postoperative pain measured daily via Visual Analog Scale (VAS), general patient comfort during daily activities such as eating and oral hygiene, and overall patient satisfaction assessed using Likert scales or validated questionnaires.
Secondary endpoints involve clinical healing evaluated clinically and photographically at 7 and 14 days postoperatively, incidence of postoperative complications (e.g., prolonged bleeding, infections), analgesic consumption, functional recovery time, and oral health-related quality of life measured by the OHIP-14 questionnaire.
Statistical analysis will compare groups using appropriate parametric or non-parametric tests for continuous variables (pain scores, recovery time) and Chi-square or Fisher's exact tests for categorical variables. Pain progression over time will be assessed using repeated-measures ANOVA or an equivalent non-parametric test.
This study will help determine whether the palatal stent represents a superior alternative to conventional techniques in improving patient comfort, healing, and postoperative oral health-related quality of life in mucogingival surgical procedures.
Read the detailed description
Objective This study aims to compare the effectiveness of palatal stent management versus conventional suturing on patient-reported outcome measures (PROMs), to identify the optimal strategy for managing palatal donor sites and improving postoperative patient well-being.
Primary Endpoints
- Postoperative Pain: Measured daily using a Visual Analog Scale (VAS) during the first postoperative week.
- General Patient Comfort: Evaluated using standardized questionnaires assessing discomfort during daily activities such as eating and oral hygiene.
- Patient Satisfaction: Assessed using Likert scales or validated questionnaires.
Secondary Endpoints
- Clinical Healing of Donor Site: Evaluated clinically (e.g., redness, swelling, infection signs) and photographically at 7 and 14 days postoperatively.
- Postoperative Complications: Frequency of events including prolonged bleeding, infection, or need for additional intervention.
- Analgesic Use: Number and duration of analgesic doses prescribed or voluntarily taken by patients.
- Functional Recovery Time: Days required for patients to resume normal activities (e.g., eating without difficulty, returning to work).
- Oral Health-Related Quality of Life: Evaluated using standardized questionnaires such as OHIP-14.
Study Design
Eligible patients will be recruited and randomized into two groups:
- Experimental Group: Palatal shield management using flowable composite resin secured by adhesion to the palatal surfaces of adjacent teeth.
- Control Group: Conventional suturing management.
Prior to the procedure, baseline clinical information including plaque index and bleeding index will be collected, and informed consent will be obtained from each patient.
Surgical Procedure Free gingival graft harvesting will be performed from the palate according to standard surgical techniques. The recipient surgical procedure is not within the scope of this study and will not influence the outcomes. In both groups, collagen sponge hemostatic dressing will be secured on the donor site using either resin or sutures.
Postoperative Care All patients will receive standardized postoperative instructions, including oral hygiene and pain management guidelines, along with analgesic prescriptions as needed. Follow-up evaluations will be conducted at 1 and 2 weeks postoperatively to assess pain (VAS), complications, and healing status. Patients will complete standardized questionnaires measuring comfort, satisfaction, and oral health-related quality of life.
Inclusion Criteria Systemically healthy patients without active periodontitis requiring periodontal or peri-implant mucogingival surgery involving palatal graft harvesting.
Independent Variables
- Donor Site Management Technique:
- Palatal stent (Experimental group)
- Conventional suture (Control group)
Dependent Variables
- Postoperative pain (VAS)
- Perceived comfort (standardized questionnaires)
- Clinical healing (clinical observations)
- Postoperative complications
- Analgesic consumption
- Functional recovery time
- Patient satisfaction
- Oral health-related quality of life (OHIP-14)
Confounding Variables
- Patient age
- Gender
- Smoking status
- Graft dimensions (width and depth)
Statistical Analysis Data will be analyzed using appropriate statistical methods to compare both groups. Continuous variables, such as pain scores and recovery time, will be analyzed using independent samples t-test or Mann-Whitney U test based on data distribution. Categorical variables, such as complications and analgesic use, will be evaluated using Chi-square or Fisher's exact test. Pain evolution over time will be assessed using repeated-measures ANOVA or non-parametric equivalents. Quality of life questionnaires (OHIP-14) and patient satisfaction scores will be analyzed using descriptive statistics and between-group comparisons.
- Conditions
- Palatal Wound
- Being tested
- Palatal stent as wound dressing, Conventional suturing
- Keywords
- Free gingival graft, Wound healing, palatal stent
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Palatal stent as wound dressingProcedure or surgery
The palatal wound after graft harvesting will be protected with a flowable composite resin adhesively secured to adjacent teeth
Conventional suturingProcedure or surgery
The wound will be covered with a collagen sponge that will be hold in place with sutures
| Study group | Role | What they receive |
|---|---|---|
| Test | Experimental | The palatal wound will be protected with composite resin Receives: Procedure: Palatal stent as wound dressing |
| Control | Active comparator | The palatal wound will be covered with collagen sponge Receives: Procedure: Conventional suturing |
What is being measured
The primary outcome is the main question the study is designed to answer.
Postoperative Pain
Measured daily using a Visual Analog Scale (VAS) during the first postoperative week.
Measured: The day of the intervention and every day for the first week
General Patient Comfort
Evaluated using standardized questionnaires assessing discomfort during daily activities such as eating and oral hygiene
Measured: The day of the intervention, every day during the first week and 14 days after the intervention
Patient Satisfaction
Assessed using Likert scales and validated questionnaires
Measured: The day of the intervention, every day during the first week and 14 days after the intervention
Secondary outcomes (5)
Clinical Healing of Donor Site
Evaluated clinically (e.g., redness, swelling, infection signs) and photographically.
Measured: At 7 and 14 days postoperatively.
Postoperative Complications
Frequency of events including prolonged bleeding, infection, or need for additional intervention
Measured: Every day during the first week
Analgesic Use
Number and duration of analgesic doses prescribed or voluntarily taken by patients
Measured: Day of the intervention and every day during the first week.
Functional Recovery Time
Days required for patients to resume normal activities (e.g., eating without difficulty, returning to work).
Measured: Every day during the first week and at day 14
Oral Health-Related Quality of Life
Evaluated using standardized questionnaires such as OHIP-14.
Measured: At day 14
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted28 Jul 2025
- Study start1 Jul 2023
- Primary completion30 Apr 2025
- Study completion15 Jul 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Palatal WoundStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 20 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Cagliari
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Nicola Alberto Valente, DDS, MS, PhD, University of Cagliari
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07089433
- Sponsor's protocol ID
- Palatal Shield
- Status last verified
- Jul 2025
- First submitted
- 20 Jul 2025
- Last updated
- 28 Jul 2025
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 28 Jul 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Morbidity Following Free Gingival Graft Harvesting With or Without the Use of the Palatal Shield Technique as a Wound Dressing: A Randomized Trial
- ClinicalTrials.gov ID
- NCT07089433
- Acronym / sponsor ID
- Palatal Shield
- Conditions
- Palatal Wound
- Keywords
- Free gingival graft, Wound healing, palatal stent
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 20 participants (actual)
- Lead sponsor
- University of CagliariUniversity, hospital or other
- Study start
- 1 Jul 2023 (actual)
- Primary completion
- 30 Apr 2025 (actual)
- Study completion
- 15 Jul 2025 (actual)
- First posted
- 28 Jul 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This randomized clinical trial aims to compare two techniques for managing the palatal donor site following gingival graft harvesting: a palatal stent made of flowable composite resin versus conventional suturing. The primary goal is to identify which method provides superior patient-reported outcomes (PROMs), thus optimizing postoperative comfort and overall patient well-being.
Systemically healthy patients, free of active periodontitis, requiring a palatal graft as part of periodontal or peri-implant mucogingival surgeries will be recruited and randomized into two groups. The experimental group will receive a palatal shield made of flowable composite resin adhesively secured to adjacent teeth, whereas the control group will undergo conventional suturing. In both groups, a collagen hemostatic sponge will be placed to aid hemostasis.
Primary endpoints include postoperative pain measured daily via Visual Analog Scale (VAS), general patient comfort during daily activities such as eating and oral hygiene, and overall patient satisfaction assessed using Likert scales or validated questionnaires.
Secondary endpoints involve clinical healing evaluated clinically and photographically at 7 and 14 days postoperatively, incidence of postoperative complications (e.g., prolonged bleeding, infections), analgesic consumption, functional recovery time, and oral health-related quality of life measured by the OHIP-14 questionnaire.
Statistical analysis will compare groups using appropriate parametric or non-parametric tests for continuous variables (pain scores, recovery time) and Chi-square or Fisher's exact tests for categorical variables. Pain progression over time will be assessed using repeated-measures ANOVA or an equivalent non-parametric test.
This study will help determine whether the palatal stent represents a superior alternative to conventional techniques in improving patient comfort, healing, and postoperative oral health-related quality of life in mucogingival surgical procedures.
Detailed description
Objective This study aims to compare the effectiveness of palatal stent management versus conventional suturing on patient-reported outcome measures (PROMs), to identify the optimal strategy for managing palatal donor sites and improving postoperative patient well-being.
Primary Endpoints
- Postoperative Pain: Measured daily using a Visual Analog Scale (VAS) during the first postoperative week.
- General Patient Comfort: Evaluated using standardized questionnaires assessing discomfort during daily activities such as eating and oral hygiene.
- Patient Satisfaction: Assessed using Likert scales or validated questionnaires.
Secondary Endpoints
- Clinical Healing of Donor Site: Evaluated clinically (e.g., redness, swelling, infection signs) and photographically at 7 and 14 days postoperatively.
- Postoperative Complications: Frequency of events including prolonged bleeding, infection, or need for additional intervention.
- Analgesic Use: Number and duration of analgesic doses prescribed or voluntarily taken by patients.
- Functional Recovery Time: Days required for patients to resume normal activities (e.g., eating without difficulty, returning to work).
- Oral Health-Related Quality of Life: Evaluated using standardized questionnaires such as OHIP-14.
Study Design
Eligible patients will be recruited and randomized into two groups:
- Experimental Group: Palatal shield management using flowable composite resin secured by adhesion to the palatal surfaces of adjacent teeth.
- Control Group: Conventional suturing management.
Prior to the procedure, baseline clinical information including plaque index and bleeding index will be collected, and informed consent will be obtained from each patient.
Surgical Procedure Free gingival graft harvesting will be performed from the palate according to standard surgical techniques. The recipient surgical procedure is not within the scope of this study and will not influence the outcomes. In both groups, collagen sponge hemostatic dressing will be secured on the donor site using either resin or sutures.
Postoperative Care All patients will receive standardized postoperative instructions, including oral hygiene and pain management guidelines, along with analgesic prescriptions as needed. Follow-up evaluations will be conducted at 1 and 2 weeks postoperatively to assess pain (VAS), complications, and healing status. Patients will complete standardized questionnaires measuring comfort, satisfaction, and oral health-related quality of life.
Inclusion Criteria Systemically healthy patients without active periodontitis requiring periodontal or peri-implant mucogingival surgery involving palatal graft harvesting.
Independent Variables
- Donor Site Management Technique:
- Palatal stent (Experimental group)
- Conventional suture (Control group)
Dependent Variables
- Postoperative pain (VAS)
- Perceived comfort (standardized questionnaires)
- Clinical healing (clinical observations)
- Postoperative complications
- Analgesic consumption
- Functional recovery time
- Patient satisfaction
- Oral health-related quality of life (OHIP-14)
Confounding Variables
- Patient age
- Gender
- Smoking status
- Graft dimensions (width and depth)
Statistical Analysis Data will be analyzed using appropriate statistical methods to compare both groups. Continuous variables, such as pain scores and recovery time, will be analyzed using independent samples t-test or Mann-Whitney U test based on data distribution. Categorical variables, such as complications and analgesic use, will be evaluated using Chi-square or Fisher's exact test. Pain evolution over time will be assessed using repeated-measures ANOVA or non-parametric equivalents. Quality of life questionnaires (OHIP-14) and patient satisfaction scores will be analyzed using descriptive statistics and between-group comparisons.
Study design
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Test | Experimental | Procedure: Palatal stent as wound dressingThe palatal wound will be protected with composite resin |
| Control | Active comparator | Procedure: Conventional suturingThe palatal wound will be covered with collagen sponge |
Who may qualify
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult, Older adult
Key inclusion criteria (5 listed)
- Adult patients (≥18 years old) requiring periodontal or peri-implant mucogingival surgery involving palatal graft harvesting.
- Systemically healthy patients without medical conditions affecting wound healing.
- Patients free of active periodontal disease at the time of surgery.
- Patients able and willing to comply with postoperative instructions, complete questionnaires, and attend follow-up appointments.
- Patients providing informed written consent to participate in the study.
Key exclusion criteria (8 listed)
- Patients with systemic diseases that could influence wound healing (e.g., diabetes, autoimmune disorders).
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Palatal stent as wound dressingThe palatal wound after graft harvesting will be protected with a flowable composite resin adhesively secured to adjacent teeth | Procedure or surgery | Test |
| Conventional suturingThe wound will be covered with a collagen sponge that will be hold in place with sutures | Procedure or surgery | Control |
Primary outcome
Postoperative Pain
Time frame: The day of the intervention and every day for the first week
Measured daily using a Visual Analog Scale (VAS) during the first postoperative week.
General Patient Comfort
Time frame: The day of the intervention, every day during the first week and 14 days after the intervention
Evaluated using standardized questionnaires assessing discomfort during daily activities such as eating and oral hygiene
Patient Satisfaction
Time frame: The day of the intervention, every day during the first week and 14 days after the intervention
Assessed using Likert scales and validated questionnaires
5 secondary outcomes
Clinical Healing of Donor Site
Time frame: At 7 and 14 days postoperatively.
Postoperative Complications
Time frame: Every day during the first week
Analgesic Use
Time frame: Day of the intervention and every day during the first week.
Functional Recovery Time
Time frame: Every day during the first week and at day 14
Oral Health-Related Quality of Life
Time frame: At day 14
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 28 Jul 2025.
- Individual participant dataSharing planned: No
Related trials for Palatal Wound
Not yet recruiting
Comparative Study of Regional Nerve Blocks in Primary Cleft Palate Repair
Cleft Lip, Cleft Palate +/- Lip
Recruiting
Dynamics of Wound Healing in Patients With Obesity
Wound Healing
Recruiting
Palatal Wound Healing After Free Gingival Graft Harvest in Diabetic Patients: A Clinical Trial
Diabetes Mellitus, Gingival Recession, Generalized
Active, not recruiting
Effect of Frankincense Versus Palatal Stent on Palatal Donor Site Healing
Palatal Donor Site Wound Healing
Recruiting
Patient-reported Outcomes of Donor Site Healing Using Different Palatal Protection Techniques
Mucosal Erosion, Gingival Recession
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Palatal stent as wound dressing and Conventional suturing in people with Palatal Wound, run by University of Cagliari at 1 site in Italy.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 28 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Postoperative Pain (time frame: The day of the intervention and every day for the first week). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Jul 2025.